News

The Buck Institute and Q Therapeutics will use their expertise in differentiating stem cells to provide key cell types needed to study Parkinson’s disease. These neural-lineage cell lines

The terms of this agreement are subject to certain provisions and performance targets as outlined in Lev’s filing on Form 8-K with the Securities and Exchange Commission. Judson

This patent is the first granted to Advanced Viral Research (ADVR) in Europe. ADVR has an extensive portfolio of the US and foreign patents including 22 issued in

This drug candidate is the ocular formulation of sonepcizumab, a humanized monoclonal antibody against sphingosine-1-phosphate. The company expects to begin Phase I clinical trials of iSONEP as a

The data were generated from three blinded studies of preclinical models of colon carcinoma randomized into three experimental groups. The models were treated with suboptimal doses of motesanib

Dr Mueller will be actively involved in the development of strategic alliances and business opportunities with other companies and organizations. Most recently, he has headed Epicenter Consulting, a

The system will be used for the treatment of immune-mediated diseases such as acute or chronic graft-versus-host disease and cutaneous T-cell lymphoma. Therakos Cellex photopheresis system is the

Antisoma will make an immediate upfront payment and fund certain research at Betagenon. Further payments will be made on achievement of development and regulatory milestones, and royalties will

In a novel mouse model of medulloblastoma, once-daily dose administration of IPI-926 resulted in 100% survival while on treatment and median overall survival of 48 days, a four-fold